PSS3 Topline Patient-Reported Outcome Results from a Multicenter, Open-Label, Phase 4 Study of Repository Corticotropin Injection in Patients with Refractory Severe Noninfectious Keratitis
Jun 1, 2021, 00:00 AM
10.1016/j.jval.2021.04.1104
https://www.valueinhealthjournal.com/article/S1098-3015(21)01321-8/fulltext
Section Title :
Section Order :
10599
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(21)01321-8&doi=10.1016/j.jval.2021.04.1104